EQS-News: MorphoSys AG / Key word: Conference
MorphoSys to Present at the 42nd Annual J.P. Morgan Healthcare Conference
08.01.2024 / 08:00 CET/CEST
The issuer is.
MorphoSys' Pelabresib Improves All Four Hallmarks of Myelofibrosis in Phase 3 MANIFEST-2 Study streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
The drug researcher Morphosys has achieved a breakthrough in clinical trials with its promising drug pelabresib against the rare blood cancer myelofibrosis. In a pivotal study, the Bavarians hit their.
MorphoSys fails secondary in blood cancer trial, sinking stock fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.